| [1] |
Ostermann M, Lumlertgul N, Jeong R, et al. Acute kidney injury [J]. Lancet, 2025, 405(10474): 241-256.
|
| [2] |
Xin W, Qin Y, Lei P, et al. From cerebral ischemia towards myocardial, renal, and hepatic ischemia: exosomal miRNAs as a general concept of intercellular communication in ischemia-reperfusion injury [J]. Mol Ther Nucleic Acids, 2022, 29: 900-922.
|
| [3] |
Yao W, Chen Y, Li Z, et al. Single cell RNA sequencing identifies a unique inflammatory macrophage subset as a druggable target for alleviating acute kidney injury [J]. Adv Sci (Weinh), 2022, 9(12): e2103675.
|
| [4] |
Hu Z, Zhan J, Pei G, et al. Depletion of macrophages with clodronate liposomes partially attenuates renal fibrosis on AKI-CKD transition [J]. Ren Fail, 2023, 45(1): 2149412.
|
| [5] |
Ferenbach DA, Sheldrake TA, Dhaliwal K, et al. Macrophage/monocyte depletion by clodronate, but not diphtheria toxin, improves renal ischemia/reperfusion injury in mice [J]. Kidney Int, 2012, 82(8): 928-933.
|
| [6] |
Wang W, Ren X, Chen X, et al. Integrin beta1-rich extracellular vesicles of kidney recruit Fn1+ macrophages to aggravate ischemia-reperfusion-induced inflammation [J]. JCI Insight, 2024, 9(2): e169885.
|
| [7] |
Freiholtz D, Bergman O, Pradhananga S, et al. SPP1/osteopontin: a driver of fibrosis and inflammation in degenerative ascending aortic aneurysm? [J]. J Mol Med (Berl), 2023, 101(10): 1323-1333.
|
| [8] |
Al-Dalahmah O, Lam M, McInvale JJ, et al. Osteopontin drives neuroinflammation and cell loss in MAPT-N279K frontotemporal dementia patient neurons [J]. Cell Stem Cell, 2024, 31(5): 676-693.e10.
|
| [9] |
Yim A, Smith C, Brown AM. Osteopontin/secreted phosphoprotein-1 harnesses glial-,immune-,and neuronal cell ligand-receptor interactions to sense and regulate acute and chronic neuroinflammation [J]. Immunol Rev, 2022, 311(1): 224-233.
|
| [10] |
Kaleta B. The role of osteopontin in kidney diseases [J]. Inflamm Res, 2019, 68(2): 93-102.
|
| [11] |
Kohl K, Herzog E, Dickneite G, et al. Evaluation of urinary biomarkers for early detection of acute kidney injury in a rat nephropathy model [J]. J Pharmacol Toxicol Methods, 2020, 105: 106901.
|
| [12] |
林玲,李京儒,沈瑞华,等. 基于生物信息学分析小鼠急性肾损伤和急性肺损伤的枢纽基因[J/OL]. 中华肾病研究电子杂志,2024, 13(3): 134-144.
|
| [13] |
Yue B, Xiong D, Chen J, et al. SPP1 induces idiopathic pulmonary fibrosis and NSCLC progression via the PI3K/Akt/mTOR pathway [J]. Respir Res, 2024, 25(1): 362.
|
| [14] |
Klement JD, Paschall AV, Redd PS, et al. An osteopontin/CD44 immune checkpoint controls CD8+ T cell activation and tumor immune evasion [J]. J Clin Invest, 2018, 128(12): 5549-5560.
|
| [15] |
Han H, Ge X, Komakula SSB, et al. Macrophage-derived osteopontin (SPP1) protects from nonalcoholic steatohepatitis [J]. Gastroenterology, 2023, 165(1): 201-217.
|
| [16] |
张隆业,刘维萍,张彦芬,等. 胰激肽原酶对他克莫司诱导的大鼠肾脏损伤的保护作用 [J/OL]. 中华肾病研究电子杂志,2021, 10(4): 198-204.
|
| [17] |
Tan TK, Zheng G, Hsu TT, et al. Matrix metalloproteinase-9 of tubular and macrophage origin contributes to the pathogenesis of renal fibrosis via macrophage recruitment through osteopontin cleavage [J]. Lab Invest, 2013, 93(4): 434-449.
|
| [18] |
Li H, Li P, Shen Q, et al. Nfil3 contributes to renal fibrosis by activating fibroblasts through directly promoting the expression of Spp1 [J]. Biochim Biophys Acta Mol Basis Dis, 2025, 1871(4): 167741.
|
| [19] |
Ye Q, Xu G, Xue C, et al. Urinary SPP1 has potential as a non-invasive diagnostic marker for focal segmental glomerulosclerosis [J]. FEBS Open Bio, 2023, 13(11): 2061-2080.
|
| [20] |
Xu L, Guo J, Moledina DG, et al. Immune-mediated tubule atrophy promotes acute kidney injury to chronic kidney disease transition [J]. Nat Commun, 2022, 13(1): 4892.
|
| [21] |
Mu YF, Mao ZH, Pan SK, et al. Macrophage-driven inflammation in acute kidney injury: therapeutic opportunities and challenges [J]. Transl Res, 2025, 278: 1-9.
|
| [22] |
Ding H, Xu Z, Lu Y, et al. Kidney fibrosis molecular mechanisms SPP1 influences fibroblast activity through transforming growth factor beta smad signaling [J]. iScience, 2024, 27(9): 109839.
|